So, my office made attendance mandatory once a week, starting today. I've been here for 1,5 hrs and have already cried, bitten a hole into my stress relief chew toy, and stuffed my face with two bags of Haribo. I can't fucking do this, someone get me out of here please 😭 @actuallyautistic
TBH, I don't know how else one could get tested in the UK (unless one had private health insurance or money to burn), but OP's profile suggested a country outside the UK.
Sure beats the crude cyclophosphamide approach to killing antibody-producing B cells that are undergoing mitosis – a protocol I applied back in my PhD times to select for monoclonal antibodies against specific tissues.
A vaccine delivered with a patch device is shown in a clinical trial to generate neutralizing antibodies against measles and rubella similar to conventional injections.
Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds
A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round.
The #COVID#XBB#variant family #booster approved in the #US for everyone older than 5 and will start being available by the end of this week. Price will be an obscene $100 per dose.
#Health "#insurance" should cover the cost, in-network, but we know how insurance finds ways to not ensure our health.
Results of a clinical trial show a vaccine delivered as a nasal spray protects healthy people against infection from the bacteria causing whooping cough infections.
Dr Ruth Crystal September 2, 2023 COVID Newsletter
"BA.2.86
Yunlong Cao reported that BA.2.86 can evade our neutralizing #antibodies, even if we had prior XBB.1.5 #infections, meaning that the new fall #vaccine may not protect well against BA. 2.86. But there is a caveat. It turns out that BA.2.86 can evade antibodies, but it is not as infectious or transmissible as other variants in circulation now.
This is reassuring. We know that antibodies from the new Fall XBB.1.5 vaccine expected out in about 2 weeks, will protect us from EG.5 and FL.1.5.1 variants which are in circulation now in the U.S. and many parts of the world.
Ben Murrell’s lab in Sweden announced that eight out of twelve blood donors with prior XBB.1.5 infection had antibodies that could neutralize BA.2.86. The updated fall booster against XBB.1.5 may provide some protection against BA.2.86. We will have to wait and see"
Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients.